ERBB2 and renal cell carcinoma: In this study, the potential target of HL-RG in the treatment of gastric cancer was studied Through PPI network analysis and molecular pairing, TGFB1, CCND1, MMP9, ERBB2, CAT, and PPARα may be the core targets of HL-RG in the treatment of RCC.